請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84613
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山(Jean-San Chia) | |
dc.contributor.advisor | 賈景山(Jean-San Chia | chiajs@ntu.edu.tw | ), | |
dc.contributor.author | Bing-Chen Wu | en |
dc.contributor.author | 吳秉宸 | zh_TW |
dc.date.accessioned | 2023-03-19T22:17:38Z | - |
dc.date.copyright | 2022-10-04 | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-09-19 | |
dc.identifier.citation | 1. Kivity, S., et al., Infections and autoimmunity--friends or foes? Trends Immunol, 2009. 30(8): p. 409-14. 2. R.T., D., Molecular mimicry: antigen sharing by parasite and host and its consequences. The American Naturalist, 1964. 98(900): p. 129-49. 3. Sfriso, P., et al., Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol, 2010. 87(3): p. 385-95. 4. Blank, M., O. Barzilai, and Y. Shoenfeld, Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol, 2007. 32(1): p. 111-8. 5. Baum, H., Molecular mimicry with MHC-derived peptides: does this underlie MHC association with autoimmune disease? Biochem Soc Trans, 1997. 25(2): p. 636-42. 6. Adderson, E.E., et al., Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol, 1998. 161(4): p. 2020-31. 7. Samarkos, M. and G. Vaiopoulos, The role of infections in the pathogenesis of autoimmune diseases. Curr Drug Targets Inflamm Allergy, 2005. 4(1): p. 99-103. 8. McCoy, L., I. Tsunoda, and R.S. Fujinami, Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity, 2006. 39(1): p. 9-19. 9. Casciola-Rosen, L., et al., Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med, 1999. 190(6): p. 815-26. 10. Utz, P.J., T.J. Gensler, and P. Anderson, Death, autoantigen modifications, and tolerance. Arthritis Res, 2000. 2(2): p. 101-14. 11. Zampieri, S., et al., Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus. Ann Rheum Dis, 2001. 60(1): p. 72-6. 12. Warnock, M.G. and J.A. Goodacre, Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases. Br J Rheumatol, 1997. 36(11): p. 1144-50. 13. Clarke, J.K., On the Bacterial Factor in the Ætiology of Dental Caries. British Journal of Experimental Pathology, 1924. 5(3): p. 141–147. 14. Igarashi, T., A. Yamamoto, and N. Goto, Direct detection of Streptococcus mutans in human dental plaque by polymerase chain reaction. Oral Microbiol Immunol, 1996. 11(5): p. 294-8. 15. Garcia, S.S., et al., Targeting of Streptococcus mutans Biofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiome. J Dent Res, 2017. 96(7): p. 807-814. 16. Krzysciak, W., et al., The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis, 2014. 33(4): p. 499-515. 17. McNeill, K. and I.R. Hamilton, Acid tolerance response of biofilm cells of Streptococcus mutans. FEMS Microbiol Lett, 2003. 221(1): p. 25-30. 18. Loesche, W.J., Role of Streptococcus mutans in human dental decay. Microbiol Rev, 1986. 50(4): p. 353-80. 19. Bowen, W.H. and H. Koo, Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms. Caries Res, 2011. 45(1): p. 69-86. 20. Yumoto, H., et al., The Pathogenic Factors from Oral Streptococci for Systemic Diseases. Int J Mol Sci, 2019. 20(18). 21. Donlan, R.M. and J.W. Costerton, Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 2002. 15(2): p. 167-93. 22. Flemming, H.C., et al., Biofilms: an emergent form of bacterial life. Nat Rev Microbiol, 2016. 14(9): p. 563-75. 23. Flemming, H.C. and J. Wingender, The biofilm matrix. Nat Rev Microbiol, 2010. 8(9): p. 623-33. 24. Serra, D.O., A.M. Richter, and R. Hengge, Cellulose as an architectural element in spatially structured Escherichia coli biofilms. J Bacteriol, 2013. 195(24): p. 5540-54. 25. Hobley, L., et al., Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes. FEMS Microbiol Rev, 2015. 39(5): p. 649-69. 26. Matsumoto-Nakano, M., Role of Streptococcus mutans surface proteins for biofilm formation. Jpn Dent Sci Rev, 2018. 54(1): p. 22-29. 27. Okshevsky, M. and R.L. Meyer, The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms. Crit Rev Microbiol, 2015. 41(3): p. 341-52. 28. Montanaro, L., et al., Extracellular DNA in biofilms. Int J Artif Organs, 2011. 34(9): p. 824-31. 29. Jung, C.J., et al., AtlA Mediates Extracellular DNA Release, Which Contributes to Streptococcus mutans Biofilm Formation in an Experimental Rat Model of Infective Endocarditis. Infect Immun, 2017. 85(9). 30. Liao, S., et al., Streptococcus mutans extracellular DNA is upregulated during growth in biofilms, actively released via membrane vesicles, and influenced by components of the protein secretion machinery. J Bacteriol, 2014. 196(13): p. 2355-66. 31. Serrage, H.J., et al., Understanding the Matrix: The Role of Extracellular DNA in Oral Biofilms. Front Oral Health, 2021. 2: p. 640129. 32. Das, T., et al., Role of eDNA on the adhesion forces between Streptococcus mutans and substratum surfaces: influence of ionic strength and substratum hydrophobicity. Langmuir, 2011. 27(16): p. 10113-8. 33. Monchois, V., R.M. Willemot, and P. Monsan, Glucansucrases: mechanism of action and structure-function relationships. FEMS Microbiol Rev, 1999. 23(2): p. 131-51. 34. Kato, C., et al., Molecular genetic analysis of the catalytic site of Streptococcus mutans glucosyltransferases. Biochem Biophys Res Commun, 1992. 189(2): p. 1184-8. 35. Banas, J.A. and M.M. Vickerman, Glucan-binding proteins of the oral streptococci. Crit Rev Oral Biol Med, 2003. 14(2): p. 89-99. 36. Mooser, G. and C. Wong, Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus. Infect Immun, 1988. 56(4): p. 880-4. 37. Wong, C., et al., Size and subdomain architecture of the glucan-binding domain of sucrose:3-alpha-D-glucosyltransferase from Streptococcus sobrinus. Infect Immun, 1990. 58(7): p. 2165-70. 38. Nakano, Y.J. and H.K. Kuramitsu, Mechanism of Streptococcus mutans glucosyltransferases: hybrid-enzyme analysis. J Bacteriol, 1992. 174(17): p. 5639-46. 39. Zhang, Q., et al., Molecular mechanisms of inhibiting glucosyltransferases for biofilm formation in Streptococcus mutans. Int J Oral Sci, 2021. 13(1): p. 30. 40. Smith, D.J., et al., Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Infect Immun, 1993. 61(7): p. 2899-905. 41. Chia, J.S., et al., Human T-cell responses to the glucosyltransferases of Streptococcus mutans. Clin Diagn Lab Immunol, 2001. 8(2): p. 441-5. 42. Langman, R.E., The specificity of immunological reactions. Mol Immunol, 2000. 37(10): p. 555-61. 43. Berzofsky, J.A. and A.N. Schechter, The concepts of crossreactivity and specificity in immunology. Mol Immunol, 1981. 18(8): p. 751-63. 44. Dimitrov, J.D., et al., Antibody polyreactivity in health and disease: statu variabilis. J Immunol, 2013. 191(3): p. 993-9. 45. Cohn, M., Degeneracy, mimicry and crossreactivity in immune recognition. Mol Immunol, 2005. 42(5): p. 651-5. 46. Jain, D. and D.M. Salunke, Antibody specificity and promiscuity. Biochem J, 2019. 476(3): p. 433-447. 47. Eisen, H.N. and A.K. Chakraborty, Evolving concepts of specificity in immune reactions. Proc Natl Acad Sci U S A, 2010. 107(52): p. 22373-80. 48. James, L.C. and D.S. Tawfik, Conformational diversity and protein evolution--a 60-year-old hypothesis revisited. Trends Biochem Sci, 2003. 28(7): p. 361-8. 49. James, L.C., P. Roversi, and D.S. Tawfik, Antibody multispecificity mediated by conformational diversity. Science, 2003. 299(5611): p. 1362-7. 50. Sethi, D.K., et al., Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity, 2006. 24(4): p. 429-38. 51. Augustyniak, D., et al., Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly. Curr Med Chem, 2017. 24(36): p. 4002-4037. 52. Fitzsimmons, C.M., et al., Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? Infect Immun, 2012. 80(12): p. 4264-70. 53. Pedroso, C., et al., Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil. Emerg Infect Dis, 2019. 25(8): p. 1485-1493. 54. Dekker, A., et al., Cross-Protection Induced by a A/MAY/97 Emergency Vaccine Against Intra-Serotype Heterologous Challenge with a Foot-and-Mouth Disease Virus from the A/ASIA/G-VII Lineage. Vaccines (Basel), 2020. 8(1). 55. Covian, C., et al., BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design. Front Immunol, 2019. 10: p. 2806. 56. Liu, Y., et al., Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes. Signal Transduct Target Ther, 2022. 7(1): p. 285. 57. Keep, S., et al., Limited Cross-Protection against Infectious Bronchitis Provided by Recombinant Infectious Bronchitis Viruses Expressing Heterologous Spike Glycoproteins. Vaccines (Basel), 2020. 8(2). 58. Zhang, J., et al., Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun, 2009. 33(3-4): p. 270-4. 59. Segal, Y. and Y. Shoenfeld, Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol, 2018. 15(6): p. 586-594. 60. Grobben, M., et al., Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife, 2021. 10. 61. Sun, K.H., et al., Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology, 1995. 85(2): p. 262-9. 62. Mostoslavsky, G., et al., Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol, 2001. 31(4): p. 1221-7. 63. Du, H., et al., Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol, 2006. 145(1): p. 21-7. 64. Ben-Yehuda, A., et al., The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun, 1995. 8(2): p. 279-91. 65. Amital, H., et al., Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol, 2005. 175(8): p. 5516-23. 66. Deocharan, B., et al., Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol, 2002. 168(6): p. 3072-8. 67. Bosch, X., M. Ramos-Casals, and M.A. Khamashta, The DWEYS peptide in systemic lupus erythematosus. Trends Mol Med, 2012. 18(4): p. 215-23. 68. DeGiorgio, L.A., et al., A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med, 2001. 7(11): p. 1189-93. 69. Cohen-Solal, J. and B. Diamond, Lessons from an anti-DNA autoantibody. Mol Immunol, 2011. 48(11): p. 1328-31. 70. Kowal, C., et al., Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A, 2006. 103(52): p. 19854-9. 71. Zhang, W., et al., Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. Autoimmunity, 2010. 43(8): p. 682-9. 72. Yadav, P., et al., Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 2011. 6(1): p. e14488. 73. Pisetsky, D.S., Immune activation by bacterial DNA: a new genetic code. Immunity, 1996. 5(4): p. 303-10. 74. Gilkeson, G.S., A.M. Pippen, and D.S. Pisetsky, Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest, 1995. 95(3): p. 1398-402. 75. Gilkeson, G.S., A.J. Pritchard, and D.S. Pisetsky, Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Clin Immunol Immunopathol, 1991. 59(2): p. 288-300. 76. Gallo, P.M., et al., Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity. Immunity, 2015. 42(6): p. 1171-84. 77. Tursi, S.A., et al., Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9. PLoS Pathog, 2017. 13(4): p. e1006315. 78. Putterman, C. and B. Diamond, Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med, 1998. 188(1): p. 29-38. 79. Beger, E., et al., A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J Immunol, 2002. 168(7): p. 3617-26. 80. Diamond, B., et al., Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. J Intern Med, 2011. 269(1): p. 36-44. 81. Zhang, W. and M. Reichlin, A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry. Clin Dev Immunol, 2008. 2008: p. 683489. 82. Mahajan, A., M. Herrmann, and L.E. Munoz, Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE. Front Immunol, 2016. 7: p. 35. 83. Bosch, X., Systemic lupus erythematosus and the neutrophil. N Engl J Med, 2011. 365(8): p. 758-60. 84. Lande, R., et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med, 2011. 3(73): p. 73ra19. 85. Gestermann, N., et al., Netting Neutrophils Activate Autoreactive B Cells in Lupus. J Immunol, 2018. 200(10): p. 3364-3371. 86. Garcia-Romo, G.S., et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med, 2011. 3(73): p. 73ra20. 87. Li, P., et al., Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol, 2021. 22(9): p. 1107-1117. 88. Yipp, B.G., et al., Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med, 2012. 18(9): p. 1386-93. 89. Chen, X., et al., Ferroptosis in infection, inflammation, and immunity. J Exp Med, 2021. 218(6). 90. Pisetsky, D.S., Anti-DNA antibodies--quintessential biomarkers of SLE. Nat Rev Rheumatol, 2016. 12(2): p. 102-10. 91. You, R., et al., Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Front Immunol, 2022. 13: p. 841732. 92. Wang, H.C., et al., New paradigm of functional regulation by DNA mimic proteins: Recent updates. IUBMB Life, 2019. 71(5): p. 539-548. 93. Wang, H.C., et al., DNA mimic proteins: functions, structures, and bioinformatic analysis. Biochemistry, 2014. 53(18): p. 2865-74. 94. Atanasiu, C., et al., Interaction of the ocr gene 0.3 protein of bacteriophage T7 with EcoKI restriction/modification enzyme. Nucleic Acids Res, 2002. 30(18): p. 3936-44. 95. Court, R., et al., The crystal structure of lambda-Gam protein suggests a model for RecBCD inhibition. J Mol Biol, 2007. 371(1): p. 25-33. 96. Dutta, A., et al., Inhibition of DNA replication factor RPA by p53. Nature, 1993. 365(6441): p. 79-82. 97. Tran, J.H. and G.A. Jacoby, Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A, 2002. 99(8): p. 5638-42. 98. Miyashita, H., et al., Lysine pyrrolation is a naturally-occurring covalent modification involved in the production of DNA mimic proteins. Sci Rep, 2014. 4: p. 5343. 99. Jumper, J., et al., Highly accurate protein structure prediction with AlphaFold. Nature, 2021. 596(7873): p. 583-589. 100. Kryshtafovych, A., et al., Critical assessment of methods of protein structure prediction (CASP)-Round XIV. Proteins, 2021. 89(12): p. 1607-1617. 101. Holm, L., Dali server: structural unification of protein families. Nucleic Acids Res, 2022. 102. Maestro, B. and J.M. Sanz, Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials. Antibiotics (Basel), 2016. 5(2). 103. Domenech, M., et al., Insight into the composition of the intercellular matrix of Streptococcus pneumoniae biofilms. Environ Microbiol, 2013. 15(2): p. 502-16. 104. Domenech, M., et al., In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes. Environ Microbiol Rep, 2015. 7(5): p. 715-27. 105. Wang, M., et al., Local and global anatomy of antibody-protein antigen recognition. J Mol Recognit, 2018. 31(5): p. e2693. 106. Mason, L.J., et al., Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity. Arthritis Res Ther, 2005. 7(5): p. R971-83. 107. Katz, J.B., W. Limpanasithikul, and B. Diamond, Mutational analysis of an autoantibody: differential binding and pathogenicity. J Exp Med, 1994. 180(3): p. 925-32. 108. Kubota, T., Y. Kanai, and N. Miyasaka, Interpretation of the cross-reactivity of anti-DNA antibodies with cell surface proteins: the role of cell surface histones. Immunol Lett, 1990. 23(3): p. 187-93. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84613 | - |
dc.description.abstract | 感染通過各類型的機制在多種自身免疫性疾病中參與自體抗原免疫耐受性的破壞。我們先前的研究結果表明,轉糖鏈球菌(S. mutans)感染可以在小鼠模型中誘導抗雙股去氧核醣核酸抗體的產生。並且,鑑於這些感染誘導的抗雙股去氧核醣核酸抗體能夠交叉辨認自轉糖鏈球菌細胞壁萃取之萄糖基轉移酶B (GtfB)蛋白,轉糖鏈球菌表面蛋白GtfB在抗雙股去氧核醣核酸抗體的感染誘導中扮演重要角色。我們提出了假說假定GtfB可能透過與去氧核醣核酸結合形成蛋白質-去氧核醣核酸複合物來誘發這些交叉反應性抗雙股去氧核醣核酸抗體的產生。在本篇研究中,我們首先預測GtfB蛋白的部分結構,並由此發現GtfB與具去氧核醣核酸結合功能之膽鹼結合蛋白之間的結構相似性。大面積的表面正電荷氨基酸暴露也支持GtfB蛋白的去氧核醣核酸結合潛力。此外,我們亦使用重組GtfB蛋白來確認交叉反應性抗雙股去氧核醣核酸抗體與GtfB交叉作用的直接性。最後,我們使用GtfB-去氧核醣核酸結合鑑定探討了GtfB蛋白的去氧核醣核酸結合能力。未切割的質粒去氧核醣核酸在提供二價離子的條件下與重組GtfB蛋白作用後能夠在膠上表現出去氧核醣核酸之條帶移動,然而已切割的質粒去氧核醣核酸則無法。這意味著GtfB可能以具去氧核醣核酸構象偏好的方式與去氧核醣核酸進行二價離子依賴性結合。總結而論,GtfB在二價離子存在下表現出具去氧核醣核酸構象偏好的去氧核醣核酸結合潛力。通過與體內之核酸相互作用,GtfB可能有助於交叉反應性抗雙股去氧核醣核酸抗體之誘導。 | zh_TW |
dc.description.abstract | Infection, through a diverse range of mechanisms, contributes to the breakdown of immunological tolerance to self-antigen in a variety of autoimmune diseases. Our previous data demonstrated that Streptococcus mutans (S. mutans) infection can induce anti-dsDNA antibody production in murine models. Furthermore, the surface protein Glucosyltransferase B (GtfB) of S. mutans plays an important role in the induction of anti-dsDNA antibodies as these induced anti-dsDNA antibodies can cross-react with GtfB protein extract from the S. mutans cell wall. We hypothesized that GtfB might induce the production of these cross-reactive anti-dsDNA antibodies by interacting with DNA to form protein-DNA complexes. Here, we first predict the structure of partial length GtfB protein and discover structure similarities between GtfB and DNA-binding choline-binding proteins. Large surface areas with exposed positively charged amino acids also support the potential DNA binding ability of GtfB protein. In addition, recombinant GtfB protein was used to confirm the direct interaction of cross-reactive anti-dsDNA antibodies with GtfB. Finally, the DNA-binding capacity of GtfB protein was investigated using the GtfB-DNA binding assay. Non-cleaved plasmid DNA undergoes band shifting on gels after incubation with recombinant GtfB supplied with divalent ion, but not cleaved plasmid DNA, implying that GtfB may divalent ion dependently bind to DNA with a DNA conformational preference. Taken together, GtfB exhibits DNA binding potential with DNA conformational preference in the presence of divalent ions. By interacting with nucleic acid in vivo, GtfB may contribute to the induction of cross-reactive anti-dsDNA antibodies. | en |
dc.description.provenance | Made available in DSpace on 2023-03-19T22:17:38Z (GMT). No. of bitstreams: 1 U0001-1609202223450900.pdf: 3832466 bytes, checksum: bf4514b25faec19e44921d417fc829a2 (MD5) Previous issue date: 2022 | en |
dc.description.tableofcontents | 致謝................................................................................I 中文摘要...........................................................................II Abstract..........................................................................III Contents............................................................................V 圖目錄............................................................................VII 表目錄...........................................................................VIII Chapter 1. Introduction.............................................................1 1.1 The induction of autoantibodies by pathogen infection..........................1 1.2 Streptococcus mutans (S. mutans)...............................................3 1.3 Biofilm........................................................................4 1.4 Glucosyltransferases (Gtfs)....................................................5 1.5 Cross-reactivity of antibodies.................................................6 1.6 The induction of anti-dsDNA autoantibodies by pathogen infection..............10 1.7 DNA mimic protein.............................................................13 Chapter 2. Purpose and Specific Aim................................................15 Chapter 3. Materials and Methods...................................................16 3.1 Bacterial strains and growth condition........................................16 3.2 Recombinant protein expression and purification...............................17 3.3 Streptococcal cell-wall-associated (CA) protein extraction....................18 3.4 Western blotting (WB).........................................................18 3.5 Anti-dsDNA antibody elution from ELISA plate wells............................19 3.6 Recombinant protein-DNA binding assay.........................................20 3.7 Protein structure prediction, comparison, and characteristic analyzation......21 Chapter 4. Results.................................................................24 4.1 The prediction of partial length GtfB 3D structure model......................24 4.2 Structure similarity and surface electrostatic potential analysis of GtfB.....26 4.3 Anti-dsDNA antibodies induced by S. mutans injection can recognize S. mutans surface protein GtfB and recombinant GtfB.........................................28 4.4 DNA-binding property of recombinant GtfB protein..............................30 Chapter 5. Discussion..............................................................34 5.1 Cross-reactive anti-dsDNA/GtfB antibodies driven by molecular mimicry.........34 5.2 Cross-reactive anti-dsDNA/GtfB antibodies driven by DNA bridge effect.........36 Chapter 6. References..............................................................38 Chapter 7. Table...................................................................53 Chapter 8. Figures.................................................................54 Chapter 9. Supplementary figures...................................................62 | |
dc.language.iso | en | |
dc.title | 探討血液循環中轉糖鏈球菌引發交互作用抗雙股去氧核糖核酸抗體生成之機制 | zh_TW |
dc.title | Mechanism of cross-reactive anti-dsDNA antibody production induced by circulating Streptococcus mutans | en |
dc.type | Thesis | |
dc.date.schoolyear | 110-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 鍾筱菁(Chiau-Jing Jung) | |
dc.contributor.oralexamcommittee | 李建國(Chien-Kuo Lee),顧家綺(Chia-Chi Ku),詹迺立(Nei-Li Chan) | |
dc.subject.keyword | 轉糖鏈球菌,萄糖基轉移酶B,去氧核醣核酸,交叉反應性抗雙股去氧核醣核酸抗體,二價離子依賴性結合, | zh_TW |
dc.subject.keyword | Streptococcus mutans,Glucosyltransferase B,DNA,Cross-reactive anti-dsDNA antibody,Divalent ion-dependent binding, | en |
dc.relation.page | 66 | |
dc.identifier.doi | 10.6342/NTU202203498 | |
dc.rights.note | 同意授權(限校園內公開) | |
dc.date.accepted | 2022-09-19 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
dc.date.embargo-lift | 2022-10-04 | - |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-1609202223450900.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 3.74 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。